Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)
All News about Calidi Biotherapeutics, Inc. Common Stock
Dow Surges 100 Points; Target Shares Fall After Q2 Results ↗
August 20, 2025
Calidi Loss Down 23 Percent in Fiscal Q2 ↗
August 08, 2025
Via The Motley Fool
Topics
Intellectual Property
New Genetic Discovery Could Boost Cancer Immunotherapy
August 06, 2025